Analyst Ratings For NASDAQ:IMMP – Prima Biomed (NASDAQ:IMMP)
Today, Maxim Group reiterated its Buy rating on NASDAQ:IMMP – Prima Biomed (NASDAQ:IMMP) with a price target of $7.00.
Some recent analyst ratings include
- 5/25/2018-Maxim Group Reiterated Rating of Buy.
- 4/19/2017-FBR & Co Reiterated Rating of Buy.
- 8/26/2016-Roth Capital Reiterated Rating of Buy.
Recent Trading Activity for NASDAQ:IMMP – Prima Biomed (NASDAQ:IMMP)
Shares of NASDAQ:IMMP – Prima Biomed closed the previous trading session at 2.56 down -0.02 0.78% with 2.640000104904175 shares trading hands.